Literature DB >> 16879541

Healthy participants in phase I clinical trials: the quality of their decision to take part.

Cheryl Rabin1, Nili Tabak.   

Abstract

AIMS AND
OBJECTIVE: This study was set out to test the quality of the decision-making process of healthy volunteers in clinical trials.
BACKGROUND: Researchers fear that the decision to volunteer for clinical trials is taken inadequately and that the signature on the consent forms, meant to affirm that consent was 'informed', is actually insubstantial.
DESIGN: The study design was quasi-experimental, using a convenience quota sample.
METHODS: Over a period of a year, candidates were approached during their screening process for a proposed clinical trial, after concluding the required 'Informed Consent' procedure. In all, 100 participants in phase I trials filled out questionnaires based ultimately on the Janis and Mann model of vigilant information processing, during their stay in the research centre.
RESULTS: Only 35% of the participants reached a 'quality decision'. There is a definite correlation between information processing and quality decision-making. However, many of the healthy research volunteers (58%) do not seek out information nor check alternatives before making a decision.
CONCLUSIONS: Full disclosure is essential to a valid informed consent procedure but not sufficient; emphasis must be put on having the information understood and assimilated. Research nurses play a central role in achieving this objective.

Entities:  

Mesh:

Year:  2006        PMID: 16879541     DOI: 10.1111/j.1365-2702.2006.01388.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  4 in total

1.  Why healthy subjects volunteer for phase I studies and how they perceive their participation?

Authors:  Luis Almeida; Benedita Azevedo; Teresa Nunes; Manuel Vaz-da-Silva; Patrício Soares-da-Silva
Journal:  Eur J Clin Pharmacol       Date:  2007-09-20       Impact factor: 2.953

2.  Vigilance in the Decision-Making Process Regarding Termination of Pregnancy Following Prenatal Diagnosis of Congenital Heart Disease-Application of the 'Conflict Decision-Making Model'.

Authors:  Yulia Gendler; Einat Birk; Nili Tabak; Silvia Koton
Journal:  Int J Environ Res Public Health       Date:  2022-07-26       Impact factor: 4.614

3.  Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.

Authors:  Jill A Fisher; Lisa McManus; Marci D Cottingham; Julianne M Kalbaugh; Megan M Wood; Torin Monahan; Rebecca L Walker
Journal:  PLoS Med       Date:  2018-11-20       Impact factor: 11.069

4.  Picking and Choosing Among Phase I Trials : A Qualitative Examination of How Healthy Volunteers Understand Study Risks.

Authors:  Jill A Fisher; Torin Monahan; Rebecca L Walker
Journal:  J Bioeth Inq       Date:  2019-11-12       Impact factor: 1.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.